Log in

NASDAQ:ALLOAllogene Therapeutics News Headlines

$49.35
-4.69 (-8.68 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$49.01
Now: $49.35
$55.00
50-Day Range
$18.89
MA: $32.45
$54.04
52-Week Range
$17.43
Now: $49.35
$55.00
Volume1.31 million shs
Average Volume859,433 shs
Market Capitalization$6.19 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Headlines

Allogene Therapeutics (NASDAQ ALLO) News Headlines

Source:
DateHeadline
Is Allogene Therapeutics (ALLO) Outperforming Other Medical Stocks This Year?Is Allogene Therapeutics (ALLO) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 22 at 12:31 PM
Allogene Therapeutics Inc (NASDAQ:ALLO) Short Interest UpdateAllogene Therapeutics Inc (NASDAQ:ALLO) Short Interest Update
www.americanbankingnews.com - May 22 at 3:10 AM
-$0.55 Earnings Per Share Expected for Allogene Therapeutics Inc (NASDAQ:ALLO) This Quarter-$0.55 Earnings Per Share Expected for Allogene Therapeutics Inc (NASDAQ:ALLO) This Quarter
www.americanbankingnews.com - May 21 at 11:56 PM
Allogene Therapeutics (NASDAQ:ALLO) Upgraded to "Buy" by Roth CapitalAllogene Therapeutics (NASDAQ:ALLO) Upgraded to "Buy" by Roth Capital
www.americanbankingnews.com - May 19 at 11:27 AM
Implied Volatility Surging for Allogene (ALLO) Stock OptionsImplied Volatility Surging for Allogene (ALLO) Stock Options
finance.yahoo.com - May 19 at 10:02 AM
Allogene Therapeutics (ALLO) in Focus: Stock Moves 6.6% HigherAllogene Therapeutics (ALLO) in Focus: Stock Moves 6.6% Higher
finance.yahoo.com - May 18 at 2:06 PM
Brokers Issue Forecasts for Allogene Therapeutics Incs FY2023 Earnings (NASDAQ:ALLO)Brokers Issue Forecasts for Allogene Therapeutics Inc's FY2023 Earnings (NASDAQ:ALLO)
www.americanbankingnews.com - May 18 at 2:58 AM
SunTrust Banks Equities Analysts Lift Earnings Estimates for Allogene Therapeutics Inc (NASDAQ:ALLO)SunTrust Banks Equities Analysts Lift Earnings Estimates for Allogene Therapeutics Inc (NASDAQ:ALLO)
www.americanbankingnews.com - May 18 at 2:58 AM
Allogene Therapeutics (NASDAQ:ALLO) Lifted to "Buy" at GuggenheimAllogene Therapeutics (NASDAQ:ALLO) Lifted to "Buy" at Guggenheim
www.americanbankingnews.com - May 15 at 5:50 PM
FBI Questions Feinstein Over Stock Trades After Seizing Burr’s PhoneFBI Questions Feinstein Over Stock Trades After Seizing Burr’s Phone
www.forbes.com - May 14 at 7:39 PM
HC Wainwright Reiterates Buy Rating for Allogene Therapeutics (NASDAQ:ALLO)HC Wainwright Reiterates Buy Rating for Allogene Therapeutics (NASDAQ:ALLO)
www.americanbankingnews.com - May 14 at 4:59 PM
Allogene Therapeutics (NASDAQ:ALLO) Price Target Raised to $50.00 at OppenheimerAllogene Therapeutics (NASDAQ:ALLO) Price Target Raised to $50.00 at Oppenheimer
www.americanbankingnews.com - May 14 at 4:59 PM
Feinstein asked basic questions by FBI over pre-pandemic stock sales, amid Burr investigationFeinstein asked 'basic questions' by FBI over pre-pandemic stock sales, amid Burr investigation
www.foxnews.com - May 14 at 2:38 PM
Heres Why Allogene Therapeutics Is Roaring Higher TodayHere's Why Allogene Therapeutics Is Roaring Higher Today
www.nasdaq.com - May 14 at 2:38 PM
Here's Why Allogene Therapeutics Is Roaring Higher TodayHere's Why Allogene Therapeutics Is Roaring Higher Today
finance.yahoo.com - May 14 at 2:38 PM
Allogene Therapeutics (NASDAQ:ALLO) Given New $44.00 Price Target at Canaccord GenuityAllogene Therapeutics (NASDAQ:ALLO) Given New $44.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - May 14 at 1:48 PM
Allogene Therapeutics (NASDAQ:ALLO) Given New $45.00 Price Target at Jefferies Financial GroupAllogene Therapeutics (NASDAQ:ALLO) Given New $45.00 Price Target at Jefferies Financial Group
www.americanbankingnews.com - May 14 at 11:18 AM
SunTrust Banks Lowers Allogene Therapeutics (NASDAQ:ALLO) to HoldSunTrust Banks Lowers Allogene Therapeutics (NASDAQ:ALLO) to Hold
www.americanbankingnews.com - May 14 at 10:39 AM
Allogene Explodes 28% After-Hours On Initial ALLO-501 DataAllogene Explodes 28% After-Hours On Initial ALLO-501 Data
finance.yahoo.com - May 14 at 4:38 AM
Allogene Therapeutics reports initial ALLO-501 phase 1 trial data; shares up 26%Allogene Therapeutics reports initial ALLO-501 phase 1 trial data; shares up 26%
seekingalpha.com - May 13 at 11:37 PM
BRIEF-Allogene Therapeutics Expects To Initiate Enrollment In Phase 1 Lymphoma Trial In Q2 2020BRIEF-Allogene Therapeutics Expects To Initiate Enrollment In Phase 1 Lymphoma Trial In Q2 2020
www.reuters.com - May 13 at 11:37 PM
American Society of Clinical Oncology (ASCO) Abstract Reports Initial ALLO-501 ALPHA Phase 1 Data in Relapsed/Refractory Non-Hodgkin LymphomaAmerican Society of Clinical Oncology (ASCO) Abstract Reports Initial ALLO-501 ALPHA Phase 1 Data in Relapsed/Refractory Non-Hodgkin Lymphoma
finance.yahoo.com - May 13 at 6:36 PM
Will Allogene Therapeutics Continue to Surge Higher?Will Allogene Therapeutics Continue to Surge Higher?
finance.yahoo.com - May 13 at 1:36 PM
Allogene Therapeutics Sees Unusually High Options Volume (NASDAQ:ALLO)Allogene Therapeutics Sees Unusually High Options Volume (NASDAQ:ALLO)
www.americanbankingnews.com - May 13 at 6:20 AM
Stock Traders Purchase Large Volume of Allogene Therapeutics Call Options (NASDAQ:ALLO)Stock Traders Purchase Large Volume of Allogene Therapeutics Call Options (NASDAQ:ALLO)
www.americanbankingnews.com - May 12 at 6:56 PM
Allogene Therapeutics Inc (NASDAQ:ALLO) Receives Average Recommendation of "Buy" from AnalystsAllogene Therapeutics Inc (NASDAQ:ALLO) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 11 at 5:44 PM
How Allogene (ALLO) Stock Stands Out in a Strong IndustryHow Allogene (ALLO) Stock Stands Out in a Strong Industry
finance.yahoo.com - May 11 at 11:44 AM
Piper Sandler Analysts Boost Earnings Estimates for Allogene Therapeutics Inc (NASDAQ:ALLO)Piper Sandler Analysts Boost Earnings Estimates for Allogene Therapeutics Inc (NASDAQ:ALLO)
www.americanbankingnews.com - May 11 at 4:42 AM
Q2 2020 EPS Estimates for Allogene Therapeutics Inc (NASDAQ:ALLO) Raised by AnalystQ2 2020 EPS Estimates for Allogene Therapeutics Inc (NASDAQ:ALLO) Raised by Analyst
www.americanbankingnews.com - May 11 at 3:20 AM
Allogene Therapeutics (NASDAQ:ALLO) Receives New Coverage from Analysts at OppenheimerAllogene Therapeutics (NASDAQ:ALLO) Receives New Coverage from Analysts at Oppenheimer
www.americanbankingnews.com - May 9 at 9:41 AM
Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2020 Results - Earnings Call TranscriptAllogene Therapeutics, Inc. (ALLO) CEO David Chang on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 4:24 AM
Allogene Therapeutics (NASDAQ:ALLO) Posts  Earnings Results, Meets EstimatesAllogene Therapeutics (NASDAQ:ALLO) Posts Earnings Results, Meets Estimates
www.americanbankingnews.com - May 8 at 10:10 PM
Allogenes (ALLO) Q1 Loss Widens Y/Y, Pipeline ProgressesAllogene's (ALLO) Q1 Loss Widens Y/Y, Pipeline Progresses
www.nasdaq.com - May 7 at 1:19 PM
Allogene Therapeutics Inc (ALLO) Q1 2020 Earnings Call TranscriptAllogene Therapeutics Inc (ALLO) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 8:19 AM
Allogene Therapeutics Reports First Quarter 2020 Financial ResultsAllogene Therapeutics Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 6 at 11:39 AM
Why Earnings Season Could Be Great for Allogene Therapeutics (ALLO)Why Earnings Season Could Be Great for Allogene Therapeutics (ALLO)
finance.yahoo.com - May 5 at 10:37 AM
Allogene Therapeutics, in Collaboration with Servier, to Present Initial Results from its Phase 1 ALPHA Study of ALLO-501 AlloCAR T™ Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical OncologyAllogene Therapeutics, in Collaboration with Servier, to Present Initial Results from its Phase 1 ALPHA Study of ALLO-501 AlloCAR T™ Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology
finance.yahoo.com - April 29 at 1:43 PM
Is a Beat in Store for Amarin (AMRN) This Earnings Season?Is a Beat in Store for Amarin (AMRN) This Earnings Season?
finance.yahoo.com - April 29 at 1:43 PM
Allogene Therapeutics to Present Preclinical Findings Supporting TurboCAR™ Technology at the American Society of Gene & Cell Therapy (ASGCT) Virtual 2020 Annual MeetingAllogene Therapeutics to Present Preclinical Findings Supporting TurboCAR™ Technology at the American Society of Gene & Cell Therapy (ASGCT) Virtual 2020 Annual Meeting
finance.yahoo.com - April 28 at 5:41 PM
Allogene Therapeutics to Report First Quarter 2020 Financial Results on May 6, 2020Allogene Therapeutics to Report First Quarter 2020 Financial Results on May 6, 2020
finance.yahoo.com - April 27 at 4:39 PM
Allogenes Shares March Higher, Can It Continue?Allogene's Shares March Higher, Can It Continue?
www.nasdaq.com - April 22 at 11:27 AM
Allogene's Shares March Higher, Can It Continue?Allogene's Shares March Higher, Can It Continue?
finance.yahoo.com - April 22 at 11:27 AM
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - April 17 at 4:28 PM
Heres Why Momentum Investors Will Love Allogene Therapeutics (ALLO)Here's Why Momentum Investors Will Love Allogene Therapeutics (ALLO)
www.nasdaq.com - April 16 at 6:14 PM
Here's Why Momentum Investors Will Love Allogene Therapeutics (ALLO)Here's Why Momentum Investors Will Love Allogene Therapeutics (ALLO)
finance.yahoo.com - April 16 at 1:13 PM
Hedge Funds Have Never Been This Bullish On Allogene Therapeutics, Inc. (ALLO)Hedge Funds Have Never Been This Bullish On Allogene Therapeutics, Inc. (ALLO)
finance.yahoo.com - March 29 at 2:11 AM
MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T™) TherapiesMaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T™) Therapies
finance.yahoo.com - March 24 at 8:57 AM
Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock?Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - March 23 at 2:11 PM
Why You Shouldnt Bet Against Allogene Therapeutics (ALLO) StockWhy You Shouldn't Bet Against Allogene Therapeutics (ALLO) Stock
www.nasdaq.com - March 20 at 1:15 PM
Why You Shouldn't Bet Against Allogene Therapeutics (ALLO) StockWhy You Shouldn't Bet Against Allogene Therapeutics (ALLO) Stock
finance.yahoo.com - March 20 at 1:15 PM
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.